PODIUM SESSION I: IMPORTANCE OF SELECTION BIAS IN HEALTH CARE RESEARCH

SB1 COMPARISON OF MEDICAL CARE CONSUMPTION BETWEEN DULOXETINE INITIATORS AND PREGABALIN INITIATORS AMONG FIBROMYALGIA PATIENTS
Sun P 1 , Peng X 2 , Sun S 3 , Novick D 4 , Faries D 2 , Andrews JS 2 , Wohlreich M 2 , Wu A 5 1 Kailo Research Group, Fishers, IN, USA, 2 Eli Lilly and Company, Inc., Indianapolis, IN, USA, 3 Kailo Research Group, Fremont, CA, USA, 4 Eli Lilly and Company, Inc., Windlesham, Surrey, UK, 5 Kailo Research Group, Los Angeles, CA, USA OBJECTIVES: To compare medical care consumption between duloxetine initiators and pregabalin initiators among fibromyalgia patients. METHODS: We conducted a retrospective cohort study based on a US national commercial claims database (2006ϳ2009). Fibromyalgia patients who initiated duloxetine or pregabalin in 2008, age 18 to 64, and maintained continuous health insurance coverage one year before and one year after initiation were assigned to duloxetine or pregabalin cohorts based on their initiated agent. Patients with pill coverage of the agents over last 90 pre-initiation days, with less than 30 supply days of the agents in the follow-up year, or with a diagnosis of depression, anxiety, DPNP, epilepsy or post-herpeticneuralgia before the initiation were excluded. Fibromyalgia-related medical care consumption (inpatient, outpatient, medication utilization) was compared between the two cohorts. Bootstrapping and propensity score stratification methods were used to adjust for distribution bias as well as cross-cohort differences in demographics, pre-index clinical and economic characteristics, and medication history. RESULTS: Compared to pregabalin initiators (nϭ4,838), duloxetine initiators (n ϭ 3033) had a similar mean initiation age (49 years), female percentage (89%), percentages of patients using inpatient care (11.6% vs. 11.4%), outpatient care (100%) and medications (92.7% vs. 92.8%) in the pre-initiation year. During the post-initiation year, duloxetine initiators had fewer patients using fibromyalgiarelated inpatient care (2.1% vs. 3.0%, pϽ0.05), fibromyalgia-related outpatient care (54.0% vs. 64.3%, pϽ0.05), specialty outpatient care (83.7% vs. 89.4%, pϽ0.05), opioids (73.5% vs. 77.1%, pϽ0.05), and non-steroidal anti-inflammatory drugs (38.8% vs. 41.1%, pϽ0.05) than pregabalin initiators did. They also had fewer inpatient admissions (0.2 vs. 0.3, pϽ0.05), fibromyalgia-related outpatient claims (4.7 vs. 8.3, pϽ0.05), specialty outpatient claims (26.1 vs. 30.4, pϽ0.05), and opioid claims (6.0 vs. 7.4, pϽ0.05). CONCLUSIONS: Among fibromyalgia patients, duloxetine initiators consumed less fibromyalgia-related inpatient, outpatient, and specialty outpatient care, and had fewer post-initiation claims for opioids. OBJECTIVES: Conventional (on-pump) coronary artery bypass grafting (CABG) is a surgical procedure used to restore blood flow to the cardiac muscle in patients with coronary artery disease. Recently, some have suggested that an off-pump CABG procedure has lesser post-operative morbidity and mortality. Few studies to corroborate this finding have been conducted in the elderly population. The purpose of this study was to compare outcomes associated with on-pump and off-pump CABG among Medicare beneficiaries. METHODS: A retrospective cohort study design was used to analyze the 5% national sample of Medicare claims data. Elderly patients (Ն65 years) who underwent CABG from July 1, 2006 to June 30, 2008 were identified using ICD-9-CM codes. Outcomes were assessed (using ICD-9-CM codes) following CABG surgery to December 31, 2008. Outcomes included acute myocardial infarction (AMI), revascularization such as percutaneous coronary intervention (PCI), stroke, in-hospital and all-cause mortality. Propensity scores were calculated to predict the likelihood of each individual receiving on-pump versus off-pump CABG surgery based on patient demographics and comorbidities (identified from January 1to June 30, 2006) which were then used to match (1:1) patients in the two groups. Conditional logistic regression was used to compare the outcomes associated with the two procedures. RESULTS: 2,760 patients (1,380 in each group) met the inclusion criteria. Patients who underwent on-pump CABG had lower odds of in-hospital mortality (OR: 0.57; 95% CI: 0.39 -0.83) and all-cause mortality (OR: 0.69; 95% CI: 0.56 -0.85) as compared to off-pump CABG patients. The procedures were found to be comparable in terms of clinical outcomes including AMI, PCI and stroke. CONCLUSIONS: This study found that in-hospital and all-cause mortality associated with on-pump CABG was lower than off-pump CABG. Further clinical trials need to be conducted to compare the safety of on-pump versus off-pump CABG among elderly patients. 
SB2 COMPARATIVE EFFECTIVENESS OF ON-PUMP AND OFF-PUMP CORONARY ARTERY BYPASS GRAFTING AMONG ELDERLY PATIENTS -A RETROSPECTIVE ANALYSIS OF MEDICARE CLAIMS DATA
SB3 INCREMENTAL CLINICAL AND ECONOMIC BURDEN OF UNCONTROLLED PARTIAL-ONSET SEIZURES IN A PRIVATELY-INSURED POPULATION
OBJECTIVES:
To assess clinical and economic consequences attributable to loss of seizure control in privately-insured patients with partial-onset seizures (POS). METHODS: Health insurance claims from 58 self-insured US companies between 1999 and 2009 were analyzed. Adult patients with POS (ICD-9: 345.4x, 345.5x, or 345.7x) receiving antiepileptic drugs (AED) were selected. A retrospective matchedcohort design was used to classify patients into cohorts of "uncontrolled POS" (Ն2 AED therapy changes, followed by Ն1 epilepsy-related inpatient/ER visit within 1 year; and Ն 1 diagnosis of POS) and "well-controlled POS" (no AED change and no epilepsy-related inpatient/ER visit). Patients in the well-controlled POS group were matched 1:1 with uncontrolled POS patients via propensity score matching. Matched cohorts were compared for healthcare resource use, morbidity, and costs. Statistical differences between cohorts were assessed using multivariate regressions, adjusted for demographics, baseline AED use, comorbidities and costs. [$11,695-$18,944] ) versus the well-controlled group. Higher direct costs for the uncontrolled POS group were observed consistently across prescription drug and medical service categories. CONCLUSIONS: Uncontrolled POS was associated with significantly higher rates of healthcare resource utilization, more frequent occurrence of fractures and head injuries, and increased direct health care costs.
RESULTS
SB4
PROPENSITY-SCORE MATCHING (PSM) TO CONTROL FOR SELECTION BIAS IN "REAL-WORLD" TREATMENT COMPARISONS: A CAUTIONARY TALE CONCERNING ANTIBIOTIC THERAPY FOR INFECTIOUS DISEASE
